Panitumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Panitumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about SaveRxCanada.to
List of countries where we can ship Panitumumab:
Latest news releases on Panitumumab:
BackgroundPatients with metastatic colorectal cancer that harbors KRAS mutations in exon 2 do not benefit from anti–epidermal growth factor receptor (EGFR) therapy.
Learn about Vectibix® (panitumumab), a treatment option for wild-type RAS metastatic colorectal cancer. See Prescribing Information and Boxed Warning.
Panitumumab SPECIAL PRECAUTIONS: Caution: • Severe infusion reactions, characterized by anaphylactic reaction, bronchospasm, fever, chills, and hypotension,
For the Patient: Panitumumab injection : Other names: VECTIBIX® • Panitumumab (pan i toom’ ue mab) is a drug that is used to treat some types of
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
Notes: The three weekly panitumumab regimen has been used in select patients. Drug status: Panitumumab is PBS authority. Cost: ~ $3,690 per cycle "How this cost is ...
Background. The anti-EGFR monoclonal antibodies panitumumab and cetuximab are effective in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic ...
Each mL of concentrate contains 20 mg panitumumab. Each single-use vial contains either 100 mg of panitumumab in 5 mL, or 400 mg of panitumumab in 20 mL.
Do not mix Vectibix with, or administer as an infusion with, other medicinal products. Do not add other medications to solutions containing panitumumab.